Dear S.R.: Tirzepatide (Zepbound), like semaglutide, is a prescription medication originally used for diabetes but now ...

The Food and Drug Administration told a federal judge Thursday that it needs more time to reconsider whether Eli Lilly’s ...

This is a prescription medication originally used for diabetes but now approved for weight loss. Most people regained weight ...

The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has ...

The market didn't appreciate Amgen 's ( AMGN 1.00%) latest clinical data update, with the biopharma's shares falling more ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...

In today's biotech news, Zepbound trial data, Regenxbio's Duchenne muscular dystrophy treatment, and Intellia's promising ...

An estimated 7.4 million people would gain access to weight-loss drugs like Ozempic and Zepbound, which have out-of-pocket ...

Data from their most serious competitor, Amgen, suggests the biotech won’t upstage the market leaders.

Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or ...

My husband and I have started taking Zepbound for various medical reasons. The medication has significantly and positively ...

WEDNESDAY, Nov. 27, 2024 (HealthDay News) -- The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has found. Zepbound reduced ...